Independent product profile

Purina Pro Plan PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food

Read the recorded recipe, market, intended use and review status below.

DogfoodDry

Product and intended use

Recorded editorial overview

This earlier overview is retained for context. Check the declarations and review status below before relying on its classification or suitability statements.

UK dog veterinary diet. Manufacturer catalogue entry. See the declared composition, nutritional analysis and feeding guidance below.

SpeciesDog
Product categoryfood
Nutrition typecomplete
FormatDry
ProcessingNot established in the reviewed record
Declared life stageNot established in the reviewed record
Record typeunverified
Review statusSource data captured; Label verification pending; Evidence applicability requires the stated ingredient and study review scope
Source check required

The previously recorded analytical basis is unverified: As supplied; manufacturer declaration. It is not used for conversions or calculations.

Manufacturer declarations describe the label. EP interpretation and ingredient research do not establish the efficacy or suitability of this finished product.

Recorded declarations and sources

Purina Pro Plan PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food – PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food – UK formulation
MarketUK
Declaration coveragepartial
Verification statusunverified
Ingredients as declaredDried poultry protein
Barley*
Corn*
Soya meal*
Pea hulls*
Corn protein meal*
Pea protein
Pork fat
Digest
Dried beet pulp*
Cellulose
Fish oil
Minerals
White bean extract (0.1%, source of amylase inhibitor)
*Carbohydrate sources
Additives as declaredNutritional additives; IU/kg:; Vit A: 30,600 ;; Vit D3: 1000;; Vit E: 560.; mg/kg:; Vit C: 140;; Iron (II) sulphate monohydrate (Fe: 120);; Calcium iodate anhydrous (I: 1.9);; Copper (II) sulphate pentahydrate (Cu: 13);; Manganous sulphate monohydrate (Mn:47);; Zinc sulphate monohydrate (Zn: 110);; Sodium selenite (Se: 0.13).; Taurine: 1000.; Antioxidants.
Manufacturer ingredient explanations and claimsNot recorded; source verification may be required
Declared nutritional analysisProtein: 37.0%; Fat: 12.0%; Crude ash: 7.0%; Crude fibre: 7.0%; Carbohydrate: 29.5%; Starch: 18.5%; Total sugar: 1.5%; Metabolisable energy: 342kcal/100g; Energy 342kcal per 100g
Analytical basisunknown
Basis preserved from the original recordAs supplied; manufacturer declaration
Basis verificationunverified
Declared energy342 kcal per 100g as supplied
Feeding guidanceFeeding guide Feeding guide The recommended period of use is initially up to 6 months. It is recommended that a veterinarian's opinion be sought before use or before extending the period of use. Water should always be available. For dogs over 70kg: for each additional 5kg of body weight, feed an additional 30g. Body weight (kg) Daily feeding quantity (g/day) 2.5 75 5 120 10 190 15 250 25 350 35 440 45 520 70 700
EP feeding limitationsNot recorded; source verification may be required
StorageNot recorded; source verification may be required
Last checked2026-09-25
Field provenanceformulation metadata

Read the recorded source

The checked date records when EP inspected or captured the source. It does not establish when the recipe changed. Calculations require verified values with a compatible basis and qualifiers.

Additional recorded source captures

A source capture records the information available within that scope. It does not by itself complete label verification or establish product efficacy.

Manufacturer claims and evidence

These statements are attributed to the manufacturer. They are separate from EP interpretation and independently reviewed ingredient research.

Manufacturer description and claims: Features Glucose control Specially formulated for the nutritional management of diabetes Low carbohydrate to help limit postprandial hyperglycaemia Contains Amylase inhibitor Phaseolamin from white bean extract to help reduce carbohydrate digestion Helps reduce post-prandial blood glucose fluctuations Contains selected sources of dietary fibre and low glycaemic index carbohydrates sources Helps reduce oxidative stress commonly found in diabetic patients Contains antioxidants including vitamin E and C Helps maintain joint mobility thanks to a source of chondroitin and glucosamine Supports patient compliance Complete dietetic dog food for the regulation of glucose supply (Diabetes mellitus) with low level of total sugars (mono- and disaccharides).

Ingredient research does not establish an effect of this finished product.

Explore ingredients and research

Ingredient profiles

Purina Pro Plan PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food – PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food – UK formulation

Linked from a partial editorial summary, not a complete manufacturer declaration.

11 label phrase(s) awaiting a reviewed profile link
  • Barley*
  • Corn*
  • Soya meal*
  • Pea hulls*
  • Corn protein meal*
  • Pea protein
  • Pork fat
  • Dried beet pulp*
  • Cellulose
  • Fish oil
  • *Carbohydrate sources

Market: UK. Source checked: 25/09/2026. Source.

Explore the available ingredient profiles. These links provide ingredient context, not proof of a benefit from this finished product.

Reviewed ingredient research context

These are reviewed ingredient connections for Purina Pro Plan PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food – PRO PLAN® VETERINARY DIETS DM Diabetes Management Dry Dog Food – UK formulation. Direct describes an ingredient relationship, not proof for this commercial product. No ingredient study is treated as a test of this finished product.

No study relationship is currently approved for this selected formulation and market. Evidence appraisal may remain pending.

Source and review scope

Current sources, checked dates, unresolved conflicts and declaration coverage appear with each recorded formulation above. Source capture, label verification, ingredient matching and evidence appraisal are separate review steps.

Further source and evidence review remains pending